12.1 Pacemaker & Transvenous ICD Implantation Techniques & Safety

12.1 Pacemaker & Transvenous ICD Implantation Techniques & Safety

Cardiac implantable electronic devices (CIEDs)—including permanent pacemakers (PPMs), implantable cardioverter-defibrillators (ICDs), and cardiac resynchronization therapy (CRT) systems—represent cornerstone therapies in electrophysiology for bradyarrhythmias, heart failure, and the prevention of sudden cardiac death (SCD). Mastery of surgical pocket anatomy, venous access alternatives, lead fixation physics, and high-voltage lead architecture is essential for the electrophysiology specialist assisting during device implantation.

---

CIED Systems Overview & Diagnostic Classifications

Implantable antiarrhythmic devices are engineered in single-chamber, dual-chamber, and triple-chamber (biventricular) configurations, each matched to specific electrophysiological indications.

Permanent Pacemakers (PPM)

• Single-Chamber Atrial (AAI / AAIR): Utilizes a single lead positioned in the right atrial appendage or atrial septum. Indicated strictly for isolated sinus node dysfunction (sick sinus syndrome) with intact, documented atrioventricular (AV) node conduction. Contraindicated in the presence of AV block, bundle branch block, or paroxysmal atrial fibrillation.
• Single-Chamber Ventricular (VVI / VVIR): Utilizes a single lead placed in the right ventricle (RV apex or septum). Indicated for chronic atrial fibrillation accompanied by symptomatic bradycardia or high-grade AV block, or for infrequent pauses where AV synchrony provides minimal hemodynamic advantage.
• Dual-Chamber (DDD / DDDR): Utilizes leads in both the right atrium and right ventricle. Paces and senses in both chambers, preserving physiological AV synchrony, minimizing pacemaker syndrome (hypotension and neck fullness caused by cannon A-waves during AV dyssynchrony), and lowering the long-term incidence of atrial fibrillation and stroke.

Implantable Cardioverter-Defibrillators (ICD)

ICD systems provide continuous cardiac rhythm monitoring, tiered antitachycardia pacing (ATP), low-energy cardioversion, and high-energy defibrillation shocks (typically 35 to 40 J delivered energy) alongside complete bradycardia backup pacing.

• Single-Chamber ICD (VR): A single high-voltage lead in the RV provides ventricular sensing, bradycardia pacing, ATP, and defibrillation.
• Dual-Chamber ICD (DR): Incorporates an atrial pacing/sensing lead alongside the high-voltage RV lead. Atrial electrograms facilitate dual-chamber discrimination algorithms (such as PR Logic or Rhythm ID) that differentiate supraventricular tachycardia (SVT / AF / atrial flutter) from true ventricular tachycardia (VT), significantly reducing inappropriate shocks.
• Clinical Indications:
  • Secondary Prevention: Patients who have survived cardiac arrest due to ventricular fibrillation (VF) or hemodynamically unstable sustained VT in the absence of a reversible metabolic or ischemic cause.
  • Primary Prevention: Patients with ischemic cardiomyopathy (prior myocardial infarction > 40 days prior, left ventricular ejection fraction [LVEF] $\le 35%$, and NYHA Class II-III symptoms despite $\ge 3$ months of optimal guideline-directed medical therapy [GDMT], or LVEF $\le 30%$ with NYHA Class I), or non-ischemic dilated cardiomyopathy (LVEF $\le 35%$, NYHA II-III on GDMT for $\ge 3$ months).

The NASPE/BPEG Generic (NBG) Pacemaker Code

The North American Society of Pacing and Electrophysiology (now Heart Rhythm Society) and British Pacing and Electrophysiology Group established the standardized 5-position NBG code to define pacemaker functionality:

In DDD mode, an intrinsic atrial event (P-wave) sensed in Position II inhibits atrial pacing and triggers an AV interval timer; if no intrinsic ventricular event (R-wave) is sensed before the programmed AV delay expires, the ventricular channel paces. In DDDR mode, an integrated sensor (such as a piezoelectric crystal, piezoresistive accelerometer, or transthoracic impedance minute ventilation sensor) drives pacing rates above the programmed lower rate during physical exercise or metabolic stress.

The NBD Defibrillator Code

A complementary 4-position code defines ICD functionality:

• Position I (Shocking Chamber): O = None, A = Atrium, V = Ventricle, D = Dual (A + V).
• Position II (Antitachycardia Pacing Chamber): O = None, A = Atrium, V = Ventricle, D = Dual.
• Position III (Tachycardia Detection): E = Electrogram analysis, H = Hemodynamic monitoring.
• Position IV (Antibradycardia Pacing Chamber): O = None, A = Atrium, V = Ventricle, D = Dual.

---

Surgical Pocket Creation & Dissection Techniques

The surgical pocket houses the pulse generator and lead slack, requiring precise anatomical dissection to balance cosmetic outcome, mechanical stability, and tissue vascularity.

Subcutaneous Tissue
       |
       v
[Pre-Pectoral Pocket]  --> Plane between subcutaneous fat & pectoralis major fascia
       |
       v
[Pectoralis Major Muscle]
       |
       v
[Sub-Muscular Pocket]  --> Plane beneath pectoralis major muscle (over ribs/pectoralis minor)

Pre-Pectoral Pocket Dissection

The standard approach involves creating an infraclavicular incision approximately 2 to 3 cm inferior and parallel to the middle third of the clavicle:

• Anatomical Plane: Dissection divides subcutaneous adipose tissue down to the glistening, fibrous investing fascia of the pectoralis major muscle. Blunt and electrocautery dissection creates a pocket overlying the muscular fascia.
• Advantages: Technically straightforward, rapid creation, minimal post-operative pain, and facile access during subsequent battery (generator) replacements.
• Disadvantages: In elderly, cachectic, or chronically ill patients with depleted subcutaneous tissue, pre-pectoral placement leaves the generator beneath a thin, fragile layer of skin, markedly increasing the risk of device migration, skin erosion, and decubitus breakdown.

Sub-Muscular (Sub-Pectoral) Pocket Dissection

• Anatomical Plane: The fibers of the pectoralis major muscle are divided along their natural striations, or the inferolateral border of the muscle is mobilized. A space is developed bluntly beneath the pectoralis major muscle, resting directly over the pectoralis minor muscle and thoracic rib cage.
• Clinical Indications: Severely cachectic or frail patients with thin skin, pediatric patients, female patients seeking superior cosmetic outcomes (hiding the generator contour), and secondary revisions following pre-pectoral skin erosion or decubitus thinning.
• Disadvantages: Increased surgical time, heightened post-operative pain requiring intensive analgesia, elevated risk of sub-muscular hematoma, and challenging lead manipulation during future revision or extraction procedures.

Hemostasis & Electrosurgery Safety

Pocket hematoma is the single greatest risk factor for subsequent CIED pocket infection and systemic endocarditis, increasing the risk of device infection by more than seven-fold. Meticulous hemostasis is mandatory:

• Cautery Modality: Bipolar electrocautery is strongly preferred over unipolar cautery. Bipolar current flows strictly between the two forceps tines, eliminating stray electrical fields.
• Unipolar Cautery Hazards: Unipolar cautery delivers high-frequency AC current that travels through the patient's body to a distant dispersive ground pad. If unipolar current contacts an existing or newly placed intracardiac lead, current travels down the low-resistance metallic conductor wire directly into the endomyocardium. This causes thermal tissue ablation at the lead tip, resulting in acute loss of capture, severe pacing threshold elevation, or permanent pulse generator reset into backup (power-on reset [POR]) mode.
• Grounding Pad Placement: When unipolar cautery must be used, the dispersive return electrode pad must be positioned on the ipsilateral thigh or lower extremity, ensuring that the electrical conduction path through the torso does not cross the heart or generator pocket.

---

Venous Access Routes: Anatomy, Techniques & Complications

Transvenous leads are introduced into the central venous circulation via one of three distinct routes: cephalic vein cutdown, subclavian vein puncture, or extrathoracic axillary vein access.

1. Cephalic Vein Cutdown

The cephalic vein courses through the deltopectoral groove between the deltoid and pectoralis major muscles. It is surgically isolated under direct vision, encircled with proximal and distal silk ligatures, and accessed via a transverse venotomy scissors cut. Leads are inserted directly through the venotomy into the axillary vein.

• Safety Profile: Because the vein is accessed entirely outside the thoracic cage under direct visual inspection, there is zero risk of pneumothorax, hemothorax, or inadvertent arterial puncture.
• Costoclavicular Sparing: The cephalic vein empties into the axillary vein lateral to the thoracic inlet, completely avoiding the costoclavicular space and eliminating subclavian crush syndrome.
• Limitations: The vein may be congenitally absent, hypoplastic, or exhibit severe acute tortuosity or valves in 15% to 25% of patients. Introducing multiple large-diameter leads (such as an ICD lead alongside a CRT LV lead) often requires vein dilation or secondary puncture.

2. Subclavian Vein Puncture & Subclavian Crush Syndrome

The traditional landmark approach involves inserting an 18-gauge needle 1 cm inferior to the junction of the medial and middle thirds of the clavicle, advancing the needle toward the suprasternal notch until venous blood is aspirated.

• Procedural Complications: Inadvertent puncture of the lung pleura occurs in 1% to 3% of landmark attempts, producing pneumothorax or tension pneumothorax requiring chest tube thoracostomy. Puncture of the underlying subclavian artery can induce severe hemothorax or mediastinal hematoma that is non-compressible due to the overlying bony clavicle.
• Subclavian Crush Syndrome: When the subclavian vein is entered medially near the costoclavicular ligament, the lead must pass through the rigid anatomical pinch-point formed by the clavicle anteriorly, the first rib posteriorly, and the subclavius muscle and costoclavicular ligament inferiorly. Repetitive mechanical compression during arm movement crushes the lead body, causing:
  1. Outer silicone or polyurethane insulation abrasion.
  2. Inner conductor coil fatigue and complete fracture.
  3. Intermittent conductor break causing false electrical noise, resulting in inappropriate high-voltage ICD shocks or inhibition of ventricular pacing.

[Clavicle] <-------------------------------------------
        \    Rigid Costoclavicular Pinch-Point        |
 [Lead] ===> [Subclavius Muscle & Ligament] ===> CRUSH INJURY
        /                                             |
[1st Rib]  <-------------------------------------------

3. Extrathoracic Axillary Vein Access

Modern implantation standards favor accessing the axillary vein lateral to the outer margin of the first rib. The operator identifies the target fluoroscopically over the body of the second rib or outer border of the first rib (often utilizing a small 5-10 mL contrast venogram in 30° RAO or AP projection) or directly visualizes the vein using real-time vascular ultrasound.

• Clinical Superiority: The axillary vein resides entirely outside the bony thoracic cage. Entering the vein lateral to the first rib prevents the lead from traversing the costoclavicular ligament, providing the complete insulation protection of a cephalic cutdown while maintaining the speed and multi-lead capacity of a percutaneous puncture. Pneumothorax rates drop to less than 0.1%.

---

Lead Technologies & Fixation Mechanisms

Pacing and ICD leads interface the pulse generator with the endocardium, requiring mechanical stability and minimal electrical resistance.

Passive vs. Active Fixation Leads

• Passive Fixation (Tined Leads): Features 2 to 4 flexible silicone tines arranged radially around the lead tip. The tines mechanically entangle within the fibrous trabeculae carneae of the RV apex or the pectinate muscles of the right atrial appendage. Within 2 to 4 weeks, fibrous tissue encapsulates the tines, securing the lead.
  • Limitations: Cannot be securely positioned on smooth endocardial surfaces (such as the ventricular septum or RV outflow tract). Once fibrosed, repositioning or transvenous lead extraction is challenging and traumatic.
• Active Fixation (Screw-in Leads): Features an electrically active extendable/retractable platinum-iridium helical screw (typically 1.5 to 2.0 mm in length) housed within the distal tip. The helix is extended into the myocardium by rotating the proximal connector pin using a specialized fixation tool or stylet.
  • Advantages: Can be securely fixed virtually anywhere on the endocardium, allowing physiological placement on the mid-interventricular septum, RV outflow tract (RVOT), or low atrial septum. If initial electrical measurements are suboptimal, the helix is retracted, and the lead is immediately repositioned. Active leads are substantially easier to extract years later.

Steroid Elution Biophysics

Mechanical penetration of the endocardium triggers an acute inflammatory cascade characterized by local tissue edema, neutrophil and macrophage infiltration, and subsequent fibrotic encapsulation. In non-steroid leads, this acute reaction causes a sharp rise in pacing capture thresholds—the acute threshold peak—which peaks 3 to 7 days post-implant at 2 to 3 times the initial implant threshold before partially settling.

Modern leads incorporate a miniature porous silicone collar saturated with dexamethasone sodium phosphate (typically < 1 mg) situated adjacent to the active helix or electrode tip. Upon blood contact, dexamethasone elutes slowly into the surrounding tissue over several months. This localized glucocorticoid concentration suppresses local phospholipase $A_2$, inhibits cytokine release, and prevents capillary leakage and edema. As a result, the acute pacing threshold peak is completely blunted, maintaining near-flat pacing thresholds from day zero throughout chronic follow-up, which directly conserves generator battery energy.

---

Defibrillator Lead Architecture: Sensing & Shocking Vectors

High-voltage transvenous defibrillator leads carry both fine sensing/pacing conductors and heavy, high-voltage conductor cables connected to large-surface-area platinum-coated titanium shocking coils.

True Bipolar:       [Tip Cathode (-)] === (8-10 mm) === [Ring Anode (+)] ... [RV Coil]
Integrated Bipolar: [Tip Cathode (-)] =============== (15-20 mm) =============== [RV Coil Anode (+)]

Sensing Configuration: True Bipolar vs. Integrated Bipolar

• True Bipolar Sensing: Features a dedicated distal pacing tip electrode (cathode) and a dedicated proximal ring electrode (anode) situated 8 to 10 mm behind the tip. Sensing occurs strictly between the tip and ring.
  • Advantages: The small inter-electrode distance (narrow dipole) ensures that only local near-field ventricular depolarizations are recorded. It provides superior rejection of far-field atrial signals, far-field T-waves, and diaphragmatic electromyographic (EMG) myopotentials.
• Integrated Bipolar Sensing: Paces and senses between the distal tip electrode (cathode) and the distal high-voltage RV shocking coil, which functions as the sensing anode.
  • Disadvantages: The distance between the tip and coil is wide (15 to 20 mm), and the shocking coil has a massive surface area compared to a small pacing ring. This wide sensing dipole is highly susceptible to far-field oversensing (recording T-waves or diaphragmatic potentials). Oversensing of T-waves or pectoral muscle potentials frequently triggers inappropriate ICD shocks for non-existent ventricular arrhythmias.

Shocking Coil Architecture: Single-Coil vs. Dual-Coil Leads

• Single-Coil Leads: Possesses a single shocking coil positioned in the right ventricle (RV coil). The defibrillation shock vector travels from the RV coil to the metallic generator can (active housing) located in the left pectoral pocket.
  • Advantages: Exhibits a thinner, more flexible lead profile, and dramatically reduces lead extraction complexity. Because no coil resides in the superior vena cava, there is no fibrous tissue ingrowth anchoring the lead to the venous wall.
• Dual-Coil Leads: Possesses both an RV shocking coil and a proximal Superior Vena Cava (SVC) coil positioned at the SVC-right atrial junction. Shock vectors can be programmed between the RV coil and the SVC coil + generator can.
  • Advantages: Generates a lower high-voltage shock impedance (typically 30 to 50 $\Omega$ versus 45 to 75 $\Omega$ for single-coil leads) and historically provided a marginally lower defibrillation threshold in right-sided or abdominal generator implants.
  • Severe Hazard during Extraction: The SVC coil sits directly against the thin, fibrous wall of the superior vena cava and innominate vein. Over years, intense fibrous tissue encapsulation and vascular ingrowth fuse the SVC coil to the venous endothelium. During transvenous lead extraction, mechanical or laser sheaths freeing an SVC coil carry an alarming risk of superior vena cava laceration, resulting in catastrophic hemothorax, cardiac tamponade, and operative mortality within minutes.